These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3597350)

  • 21. NMR studies of internal dynamics of serine proteinase protein inhibitors: Binding region mobilities of intact and reactive-site hydrolyzed Cucurbita maxima trypsin inhibitor (CMTI)-III of the squash family and comparison with those of counterparts of CMTI-V of the potato I family.
    Liu J; Gong Y; Prakash O; Wen L; Lee I; Huang JK; Krishnamoorthi R
    Protein Sci; 1998 Jan; 7(1):132-41. PubMed ID: 9514268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystallization of Bowman-Birk type protease inhibitor (peanut) and its complex with trypsin.
    Tsunogae Y; Suzuki A; Sone T; Takahashi K; Tanaka I; Yamane T; Ashida T; Norioka S; Hara S; Ikenaka T
    J Biochem; 1986 Jul; 100(1):243-6. PubMed ID: 3759935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
    Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
    J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical-enzymatic replacement of Ile64 in the reactive site of soybeen trypsin inhibitor (Kunitz).
    Kowalski D; Laskowski M
    Biochemistry; 1976 Mar; 15(6):1300-9. PubMed ID: 1252449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-function relationship of serine protease-protein inhibitor interaction.
    Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
    Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure of the trypsin-binding domain of Bowman-Birk type protease inhibitor and its interaction with trypsin.
    Tsunogae Y; Tanaka I; Yamane T; Kikkawa J; Ashida T; Ishikawa C; Watanabe K; Nakamura S; Takahashi K
    J Biochem; 1986 Dec; 100(6):1637-46. PubMed ID: 3032921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substitutions at the P(1) position in BPTI strongly affect the association energy with serine proteinases.
    Grzesiak A; Helland R; Smalås AO; Krowarsch D; Dadlez M; Otlewski J
    J Mol Biol; 2000 Aug; 301(1):205-17. PubMed ID: 10926503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of lysine 60f to S1' specificity of thrombin.
    Rezaie AR; Olson ST
    Biochemistry; 1997 Feb; 36(5):1026-33. PubMed ID: 9033392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of the anticarcinogenic Bowman-Birk inhibitor from snail medic (Medicago scutellata) seeds complexed with bovine trypsin.
    Capaldi S; Perduca M; Faggion B; Carrizo ME; Tava A; Ragona L; Monaco HL
    J Struct Biol; 2007 Apr; 158(1):71-9. PubMed ID: 17142058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypsin reactivity site of the Vicia angustifolia proteinase inhibitor.
    Abe O; Shimokawa Y; Araki T; Kuromizu K
    J Biochem; 1978 Jun; 83(6):1749-56. PubMed ID: 670165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific modification of the functional arginine residue in soybean trypsin inhibitor (Kunitz) by peptidylarginine deiminase.
    Takahara H; Okamoto H; Sugawara K
    J Biol Chem; 1985 Jul; 260(14):8378-83. PubMed ID: 3874206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
    Kojima S; Nishiyama Y; Kumagai I; Miura K
    J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
    Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
    Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors.
    Weder JK; Hinkers SC
    J Agric Food Chem; 2004 Jun; 52(13):4219-26. PubMed ID: 15212472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of reactive site location on the inhibitory properties of the serpin alpha(1)-antichymotrypsin.
    Plotnick MI; Rubin H; Schechter NM
    J Biol Chem; 2002 Aug; 277(33):29927-35. PubMed ID: 12055188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distance between the basic group of the amino acid residue's side chain in position P1 of trypsin inhibitor CMTI-III and Asp189 in the substrate pocket of trypsin has an essential influence on the inhibitory activity.
    Jaśkiewicz A; Lesner A; Rózycki J; Rodziewicz S; Rolka K; Ragnarsson U; Kupryszewski G
    Biochem Biophys Res Commun; 1997 Nov; 240(3):869-71. PubMed ID: 9398660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction of alpha-hydroxymethyamino acid residues in substrate specificity P1 position of trypsin inhibitor SFTI-1 from sunflower seeds retains its activity.
    Zabłotna E; Kret A; Jaśkiewicz A; Olma A; Leplawy MT; Rolka K
    Biochem Biophys Res Commun; 2006 Feb; 340(3):823-8. PubMed ID: 16380077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational design and characterization of D-Phe-Pro-D-Arg-derived direct thrombin inhibitors.
    Figueiredo AC; Clement CC; Zakia S; Gingold J; Philipp M; Pereira PJ
    PLoS One; 2012; 7(3):e34354. PubMed ID: 22457833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing the inhibitory specificity and function of Cucurbita maxima trypsin inhibitor-V by site-directed mutagenesis.
    Wen L; Lee I; Chen G; Huang JK; Gong Y; Krishnamoorthi R
    Biochem Biophys Res Commun; 1995 Feb; 207(3):897-902. PubMed ID: 7864895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural characterization by nuclear magnetic resonance of a reactive-site 13carbon-labelled basic pancreatic trypsin inhibitor with the peptide bond Arg-39--Ala-40 cleaved and Arg-39 removed.
    Richarz R; Tschesche H; Wüthrich K
    Eur J Biochem; 1979 Dec; 102(2):563-71. PubMed ID: 527593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.